Diagnostic accuracy of combinations of serological biomarkers for identifying clinical tuberculosis

Introduction: Confirmation of tuberculosis (TB) cases in endemic TB settings is a challenge; obtaining fast and cheap, though accurate, diagnostic tools such as biomarkers is thus urgently needed to enable the early detection of TB. This paper evaluates the diagnostic accuracy of combinations of hos...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/20325
Acceso en línea:
https://repository.urosario.edu.co/handle/10336/20325
Palabra clave:
Anti P 12033
Anti P 12034
Anti P 12037
Anti P 29878
Biological Marker
Cd14 Antigen
Cxcl9 Chemokine
Early Secretory Antigenic Target 6
Gelatinase B
Immunoglobulin G
Peptide Antibody
Synthetic Peptide
Unclassified Drug
Urokinase Receptor
Amino Acid Sequence
Area Under The Curve
Bacterium Culture
Blood Examination
Clinical Feature
Controlled Study
Delayed Hypersensitivity
Diagnostic Accuracy
Diagnostic Test Accuracy Study
Enzyme Linked Immunosorbent Assay
Human
Immunoreactivity
Latent Tuberculosis
Major Clinical Study
Male
Mycobacterium Tuberculosis
Predictive Value
Receiver Operating Characteristic
Sensitivity And Specificity
Sputum Analysis
Staining
Thorax Radiography
Tuberculin Test
Tuberculosis
X Ray
Biología
Bacterial antigen
Cd14 Antigen
Amino acid sequence
Adult
Article
Female
Marcadores bioquímicos
Rights
License
Abierto (Texto Completo)
Description
Summary:Introduction: Confirmation of tuberculosis (TB) cases in endemic TB settings is a challenge; obtaining fast and cheap, though accurate, diagnostic tools such as biomarkers is thus urgently needed to enable the early detection of TB. This paper evaluates the diagnostic accuracy of combinations of host serological biomarkers for identifying TB. Methodology: Enzyme-linked immunosorbent assays (ELISA) were used on 70 Venezuelan Creole individuals for evaluating host biomarkers (i.e. CXCL9, sCD14, MMP9 and uPAR proteins) and anti-synthetic peptides covering certain Mycobacterium tuberculosis (Mtb) ESAT-6 (P-12033, P-12034 and P-12037) and Ag85A (P-29878) antigen sequences. The target population consisted of adults having active TB (ATB, n = 28), the tuberculin skin test positive (TST+) or individuals with latent TB infection (LTB, n = 28) and TST- or control subjects (CTRL, n = 14). Results: Receiver operator curve (ROC) analysis revealed good biosignature discriminative ability for 5 serological biomarkers; the accuracy of 3 combinations had a good discriminative ability for diagnosing TB. Anti-P-12034/uPAR detected TB with 96.7% sensitivity and 86.0% specificity, followed by anti-P-12033/uPAR having 96.7% sensitivity and 81.4% specificity. Anti-P-29878/MMP9 had the highest sensitivity (100%), but low specificity (52.17%). Biomarker combinations did not prove efficacious for identifying incipient subclinical TST+TB− subjects at high-risk for TB. Conclusions: The anti-P-12034/uPAR combination could be useful for identifying clinical TB patients. Such an approach holds promise for further validation. © 2018 Araujo et al.